Literature DB >> 11166084

Fixation stability in schizophrenia, bipolar, and control subjects.

D C Gooding1, J A Grabowski, C S Hendershot.   

Abstract

A few investigators have suggested that visual fixation abnormalities may serve as an endophenotype of liability for schizophrenia. However, the data are equivocal. Conflicting reports regarding the specificity of fixation deficits to schizophrenia may be attributable to methodological differences. Thirty-four schizophrenia patients, 20 bipolar patients, and 30 non-patient controls were presented targets for central fixation. Fixation was scored in terms of frequency of saccades as well as qualitative ratings. Analysis of variance on the number of saccades produced during fixation revealed that the three groups did not differ. Similarly, we observed that the schizophrenia patients did not differ from either bipolar patients or controls in terms of ratings of fixation quality. It appears that schizophrenia patients are not characterized by poor visual fixation. The findings are discussed in terms of the viability of visual fixation as a marker of schizophrenic diathesis, as well as possible implications for the analysis of schizophrenia patients' visual search performance.

Entities:  

Mesh:

Year:  2000        PMID: 11166084     DOI: 10.1016/s0165-1781(00)00226-2

Source DB:  PubMed          Journal:  Psychiatry Res        ISSN: 0165-1781            Impact factor:   3.222


  12 in total

1.  Active eye fixation performance in 940 young men: effects of IQ, schizotypy, anxiety and depression.

Authors:  N Smyrnis; E Kattoulas; I Evdokimidis; N C Stefanis; D Avramopoulos; G Pantes; C Theleritis; C N Stefanis
Journal:  Exp Brain Res       Date:  2003-12-19       Impact factor: 1.972

Review 2.  The tell-tale tasks: a review of saccadic research in psychiatric patient populations.

Authors:  Diane C Gooding; Michele A Basso
Journal:  Brain Cogn       Date:  2008-10-23       Impact factor: 2.310

Review 3.  The endophenotype concept in psychiatric genetics.

Authors:  Jonathan Flint; Marcus R Munafò
Journal:  Psychol Med       Date:  2006-09-18       Impact factor: 7.723

4.  Eye movement deficits in schizophrenia: investigation of a genetically homogenous Icelandic sample.

Authors:  H Magnus Haraldsson; Ulrich Ettinger; Brynja B Magnusdottir; Thordur Sigmundsson; Engilbert Sigurdsson; Hannes Petursson
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2008-04-24       Impact factor: 5.270

5.  Visual scan paths in first-episode schizophrenia and cannabis-induced psychosis.

Authors:  Philip J Benson; Ute Leonards; Robert M Lothian; David M St Clair; Marco C G Merlo
Journal:  J Psychiatry Neurosci       Date:  2007-07       Impact factor: 6.186

6.  Eye movement dysfunction in first-degree relatives of patients with schizophrenia: a meta-analytic evaluation of candidate endophenotypes.

Authors:  Monica E Calkins; William G Iacono; Deniz S Ones
Journal:  Brain Cogn       Date:  2008-10-18       Impact factor: 2.310

7.  The relation between antisaccade errors, fixation stability and prosaccade errors in schizophrenia.

Authors:  Jason J S Barton; Manisha Pandita; Katy Thakkar; Donald C Goff; Dara S Manoach
Journal:  Exp Brain Res       Date:  2007-12-05       Impact factor: 1.972

Review 8.  Saccadic eye movement applications for psychiatric disorders.

Authors:  Juliana Bittencourt; Bruna Velasques; Silmar Teixeira; Luis F Basile; José Inácio Salles; Antonio Egídio Nardi; Henning Budde; Mauricio Cagy; Roberto Piedade; Pedro Ribeiro
Journal:  Neuropsychiatr Dis Treat       Date:  2013-09-16       Impact factor: 2.570

Review 9.  Eye Movement in Unipolar and Bipolar Depression: A Systematic Review of the Literature.

Authors:  Nicolas Carvalho; Eric Laurent; Nicolas Noiret; Gilles Chopard; Emmanuel Haffen; Djamila Bennabi; Pierre Vandel
Journal:  Front Psychol       Date:  2015-12-15

10.  Abnormal contextual modulation of visual contour detection in patients with schizophrenia.

Authors:  Michael-Paul Schallmo; Scott R Sponheim; Cheryl A Olman
Journal:  PLoS One       Date:  2013-06-18       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.